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ABSTRACT  We  have  characterized  the  association  of  the  intermediate  filament  protein, 
vimentin,  with the plasma  membrane,  using  radioiodinated  lens vimentin  and various  prepa- 
rations  of  human  erythrocyte  membrane  vesicles.  Inside-out  membrane  vesicles  (IOVs), 
depleted of spectrin and actin, bind 1125-vimentin in a saturable  manner unlike resealed,  right- 
side-out  membranes  which  bind  negligible  amounts  of vimentin  in  an  unsaturable  fashion. 
The  binding  of vimentin  to  IOVs  is abolished  by trypsin  or acid  treatment  of the  vesicles. 
Extraction  of protein  4.1  or  reconstitution  of the  membranes  with  purified  spectrin  do  not 
basically  affect  the association.  However,  removal  of ankyrin  (band 2.1) significantly  lowers 
the  binding.  Upon  reconstitution  of  depleted  vesicles  with  purified  ankyrin,  the  vimentin 
binding function  is restored.  If ankyrin  is added  in excess the binding of vimentin  to IOVs is 
quantitatively  inhibited,  whereas  protein  4.1,  the  cytoplasmic  fragment  of  band  3,  band  6, 
band 4.5 (catalase), or bovine  serum albumin  do not influence  it.  Preincubation  of the  IOVs 
with  a  polyclonal  anti-ankyrin  antibody  blocks  90%  of  the  binding.  Preimmune  sera  and 
antibodies against  spectrin,  protein 4.1, glycophorin A, and  band 3 exhibit  no effect.  On the 
basis  of  these  data,  we  propose  that  vimentin  is  able  to  associate  specifically  with  the 
erythrocyte membrane skeleton and that ankyrin constitutes  its major attachment site. 
Eucaryofic cells possess a  complex interconnecting network 
of microfilaments and tubules that seem to be involved in a 
variety of diverse  functions  (cell  shape,  contractility,  loco- 
motion, etc.). This network, referred to as the cytoskeleton, 
organizes  the  cell  interior  into  three  topologically distinct 
domains.  The bulk of the cytoskeleton makes up a  matrix 
which extends throughout the cytoplasm, linking neighboring 
organeUes  together and providing some internal order which 
may serve to coordinate activities of  the different components 
(1). 
A special subset ofcytoskeletal proteins, some with features 
quite unlike those that make up the cytoplasmic matrix, are 
concentrated in the submembranous regions of cells and have 
come  to  be  known  as  the  membrane  skeleton  (2-8).  In 
addition to providing structural stability to the overlying lipid 
bilayer (a function most pronounced in the case of the mem- 
brane skeletons of erythrocytes), the membrane skeleton oc- 
cupies  a  critical  position  situated  as  it  is  at  the  interface 
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between the surface membrane and the cell interior, and it is 
likely that it plays some role in relaying signals from the cell 
surface to different effector systems located in the cytoplasm 
or the nucleus. 
A third region where cytoskeletal elements are concentrated 
is the perinuclear region. This especially applied to interme- 
diate flaments and microtubules (1,9- l l). Thus, the interface 
between the nucleoplasm and the cytoplasm might be consid- 
ered analogous in  some ways to the cell surface membrane 
skeleton. 
The mechanisms of assembly of the macromolecular com- 
plexes  of each  cytoskeletal  subdomain  also  seem  to  have 
characteristic features. The subunits of  the cytoplasmic matrix 
cytoskeleton assemble via mass-action-driven polymerization 
reactions (12). The individual molecules are designed for self- 
assembly and the  processes are regulated by the  local ionic 
milieu, metabolic co-factors, and accessory proteins (13). 
However, our understanding of the factors that control the 
1955 assembly of the membrane skeleton and the perinuclear cy- 
toskeleton are less clear,  since in both cases filaments must 
link up with membranes. With respect to intermediate-sized 
(or 10-nm) filaments, specific contacts have been morpholog- 
ically  identified  in  specialized regions of the plasma mem- 
brane such as the desmosomal plaques (14). Also, in lens and 
avian erythrocytes there is some evidence in favor of a  side- 
on  or end-on  attachment of the  filaments to  unspecialized 
regions of the plasma membrane (l 5,  16,  17). Still, the precise 
molecular mechanism of these interactions remains obscure. 
We have found that inverted human erythrocyte membrane 
vesicles, or inside-out membrane vesicles, (IOVs) ~ is a useful 
model system to explore the factors that regulate interactions 
between the intermediate filament subunits and membranes, 
because these membranes retain binding sites for the inter- 
mediate filament protein, vimentin. This protein is normally 
present  in  appreciable  amounts in  developing  erythroblasts 
but not in the mature mammalian erythrocytes (18,  19). The 
binding of vimentin to IOVs can be studied  under in  vitro 
conditions, and the search for the receptors involved has been 
simplified  by  the  fact that  IOVs  contain  a  relatively  small 
number of protein classes. 
We found that human erythrocyte IOVs bind vimentin by 
a  specific  high-affinity  association with ankyrin, one of the 
proteins that also links spectrin  to the inner surface  of the 
membrane. 
MATERIALS  AND  METHODS 
Chemicals:  Ultrapure  urea, ammonium sulfate, and Tris (base) were 
purchased from Schwarz/Mann  (Spring Valley, NY), trypsin from Miles Lab- 
oratories  Inc. (Elkhart,  IN), bovine  serum albumin (BSA) (R1A grade) from 
Sigma Chemical Co. (St. Louis, MO), DEAE-cellulose from Whatman Labo- 
ratory Products Inc., (Maidstone, Kent, England), and Bolton-Hunter  reagent- 
'2~I from Amersham Corp. (Arlington Heights, IL). 
Membranes:  IOVs were obtained after a 20-min extraction  of washed 
erythrocyte ghosts with 30-40 vol of 0.3 mM NaPO4, 0.1  mM EDTA, and  l 
mM phenylmethylsulfonyl fluoride (PMSF) (pH 9.0) at 37"C. Resealed ghosts 
were prepared by incubating erythrocyte ghosts in 20 vol of  phosphate-buffered 
saline (PBS), l  mM PMSF for 20 rain,  at 37"C. Right-side-out vesicles were 
made as previously described (20) except that the  medium also contained  2 
mM  MgCl2. "Stripping"  of the  IOVs or partial  removal  of protein  4.1  was 
achieved by the method of Hargreaves et al. (21). All preparations were kept in 
5 mM NaPO4, l mM PMSF on ice for a maximum of 6 d. Human blood was 
collected from normal donors while bovine blood was obtained  from a local 
slaughterhouse. 
Protein Purification:  The purification, characterization,  and radiola- 
beling of  calf lens vimentin are described in the accompanying report. Vimentin 
at  100 ~g/ml was primarily (84%) migrating as a homogeneous soluble species 
with an S coefficient of 6-75  in isokinetic sucrose gradients. Protein 4. l and 
ankyrin  were extracted  from IOVs by l  M KCI and further purified by ion- 
exchange chromatography  (22). Band 4.5  was purified from ghosts obtained 
after lysis in 2 mM MgCl2, 5 mM NaPO4, subsequent extraction with 0.3 mM 
NaPO4, 2 mM EDTA, and finally, ion-exchange chromatography  (Georgatos, 
S. D., manuscript  in preparation).  Partially purified band 6 was prepared after 
a 20-min extraction of erythrocyte ghosts with 20 vol of PBS, l mM PMSF at 
0*C. The cytoplasmic 43,000-mol-wt peptide of band 3 was isolated according 
to the method of Bennet and Stenbuck (23). 
Antibodies:  The characterization  of anti-band 3, anti-glycophorin  A, 
and anti-spectrin  are reported elsewhere (24, 25, 26). The characterization  of 
anti-protein  4.1  is to be reported  elsewhere (Leto, T.,  and V. T.  Marchesi, 
manuscript in preparation). 
Reconstitution of lOWs:  For spectrin reconstitution,  500 #g/ml of 
IOVs were incubated  with  112 vg/ml of column-purified  spectrin for 60 rain 
at 4°C in  150  mM  KCI, 5  mM Tris-HC1, 0.03  mM  PMSF  (pH 7.4). The 
membranes were pelleted and then washed twice with the same media.  For 
ankyrin  reconstitution,  500 ~g/ml of stripped IOVs were incubated  as above 
Abbreviations used in this paper:  IOVs, inside-out membrane ves- 
icles;  PMSF, phenylmethylsulfonyl fluoride. 
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with 90 #g/ml of purified ankyrin  with the exception that PMSF at 0.1  mM 
and 2 mM 2-mercaptoethanol  were also included. Membranes were washed as 
previously described.  Both  preparations  were used  immediately  for binding 
studies. 
Binding  Assays:  In general,  20  gg of membranes were mixed  and 
purified '25I-vimentin (50,000-70,000  cpm/~g) in  150 mM KCI, 5 mM Tris- 
HCI, 2 mM MgC12, 0.03 mM PMSF (pH 7.4), or PBS at a final volume of 100- 
150  #1.  0.1  mg/ml of BSA was also  included  to prevent  adsorption  to the 
plastic. Vimentin was kept in low salt on ice at 0. l mg/ml and it was adjusted 
to the proper salt concentration  immediately  prior to the assay. The mixture 
was incubated  for 90 rain at 23"C and then transferred to hard polyethylene 
400-~1 tubes  and  layered over  a  150-/al sucrose  cushion  (4%  sucrose  [iso- 
tonic]). Samples were centrifuged for exactly 12 min in a mini-fuge ( 15,000 g), 
frozen in liquid N2, and the bottoms of the tubes dissected with a razor blade. 
The pellet containing  tips and the rest of the tube were counted  in a gamma 
counter (supernate and pellet). 
The pelleting system was prestandardized as follows. Blank samples contain- 
ing only vimentin or only membranes were processed as described above. After 
freezing in liquid N2, the tubes were serially dissected and the pieces counted 
for radioactivity  or analyzed by SDS PAGE. In a different series of pretests, 
blank  samples containing  buffer and a trace  quantity  of bromophenol blue 
were pelleted, dissected, and analyzed spectrophotometrically at 700 nm. From 
such assays it was found that only 0.3% of '251-vimentin was sedimenting  in 
the absence of membranes,  >95%  of the vesicles were pelleted after a  12-min 
spin, and no dye had penetrated the sucrose cushion by the end of the run. 
Competition Assays:  P2Lvimentin  (10 ~g/ml;  50,000 cpm/#g) was 
mixed  with  20  ~g of IOVs  and  increasing  amounts of various  membrane 
polypeptides in isotonic salt (pH 7.4) at a final volume of 100 #l. Samples were 
processed for quantitation  as described above in Binding  Assays. 
Blocking by Antibodies:  Increasing amounts of specific antibodies 
up to saturating levels (empirically determined  by SDS PAGE) were added to 
20 ~g of IOVs in PBS, 0. l mM PMSF. After an incubation  period of 60 rain 
at 4"C, equal amounts of 12Sl-vimentin (12/~g/ml) were added and the system 
was allowed to equilibrate for another 90 min at 23"C. Bound and nonbound 
vimentin was quantitated  as previously described. 
As assays were executed  in  triplicate,  except  those  shown in  Fig.  l  (six 
independent  observations) and in Fig. 7 (duplicates). 
Immunoblotting:  [0% polyacrylamideSDSgelsweretransferredelec- 
truphoretically to nitrocellulose filters for 24 h. After transfer, the filters were 
washed in isotonic buffered saline and then incubated for l h at 37"C, and then 
again for 24 h at room temperature,  with 3%  BSA. Incubation  with a  l:100 
dilution  of anti-ankyrin  followed for 8 h at room temperature.  After washing 
(6 changes of buffer), 1251-protein A from Staphylococceus aureus  was added 
and the  filters were incubated  for 4 h. Finally, the nitrocellulose was washed 
for 6 h with buffer (6 changes) and for another 8 h with 0.01% Triton X-100. 
Dried filters were exposed at -70"C for 5 d. 
Electrophoresis:  Regular  10% gels or 5-10%  gradient gels were pre- 
pared according to the method of Laemmli (27). Two-dimensional  gels were 
made as described by O'Farrell (28). 
Protein Determinations:  Protein was measured according to Lowry 
(29) using BSA as a standard. 
RESULTS 
Vimentin  Binds Specifically to the Inner Surface 
of the Human Erythrocyte Membranes 
Purified I12S-vimentin  (see accompanying report) binds to 
IOVs,  prepared  from  human erythrocyte membranes,  in  a 
concentration-dependent, saturable manner. In contrast, the 
binding of vimentin to either resealed ghost membranes or 
right-side-out membrane vesicles is nonsaturable and in  an 
order of magnitude less than to IOVs (Fig.  1A). When vimen- 
tin was incubated with saturating amounts of IOVs, >80%  of 
the intermediate filament protein bound to the membranes 
(Fig.  l B), indicating that the vimentin bound to the erythro- 
cyte IOVs is not a special subset of vimentin molecules. The 
polymerization state  of vimentin  played  some  role  in  the 
capacity of vimentin to bind to IOVs. Vimentin prepolymer- 
ized before being exposed to IOVs bound to a  lesser extent 
than nonprepolymerized material when assessed under non- 
equilibrium conditions. Under these conditions, the vimentin FIGURE  1  (A) Binding of purified '2Sl-vimentin 
to IOVs  or right-side-out vesicles.  For details, 
see Materials and Methods. (Resealed ghosts 
gave similar values as the right-side-out vesi- 
cles.)  (B)  The  vimentin-binding capacities  of  A 
IOVs and right-side-out vesicles. The assay  vol-  _~ s0 
ume was 100 #1 and the final vimentin concen-  .~ 
tration 9.8/~g/ml. (C) The effect of vimentin's  ~ 
polymerization  state in the binding. ~2Sl-Vimen- 
tin at 200 #g/ml was divided in two. One half  ~  40 
was  kept  on  ice  in  5  mM  NaPO4, 0.03  mM 
PMSF, 2 mM 2-mercaptoethanol  (pH 7.5)  while  ~  30 
the other was induced to polymerize by (a) the  > 
addition of salt (final concentrations lX  PBS,  [  z0 
0.03 mM PMSF,  2 mM 2-mercaptoethanol [pH 
7.5]) and (b) an incubation of 1 h at 23"C. An  ~  10 
aliquot was taken from each preparation and  ¢, 
mixed with increasing quantities of IOVs to give  ~  00 
a final vimentin concentration of 60 #g/ml. The 
samples were incubated in phosphate-buffered 
saline for 10 min at 23*C and then processed 
as described in Materials and Methods. A, non- 
assembled vimentin; O, pre-assembled vimen- 
tin. 
A 
1.2 
oa 
E 
0,6 
.=_  0.4  \ 
\x 
02  \ 
\\ 
0.0  20  40  60  80 
-0.2 
Z-0.4 
o  ~  -0.6 
-0.8 
-I.0 
100  oa  /.o  ~'.z  J~.4  r~.e  ila  z.0 
B 
0.0 
Vimentin bound ~ug/i~ vesicles)  log F 
FIGURE 2  (A) Analysis of the  binding data  presented  in  Fig. 1A 
according to  Scatchard  (43). The  nonspecific  binding  has  been 
subtracted.  (B) Analysis of the binding data according to Hill. The 
Hill coefficient is estimated to be 1.007. 
concentration and  the quantity of membrane vesicles were 
exactly the same (Fig.  l C). 
An  analysis of vimentin binding  to  IOVs at equilibrium 
(see below) using the Scatchard plot (Fig.  2A) suggested that 
vimentin bound to a single class of acceptor sites,  present at 
an approximate concentration of 80 ~g/mg of IOVs. Assum- 
ing that the smallest vimentin aggregate in solution under the 
conditions  of incubation  was a  tetramer (30),  the  KD was 
estimated to be 3  ×  l0 -7  M. Plotting the data according to 
Hill (Fig. 2 B) revealed no apparent cooperativity in the bind- 
ing process (Hill coefficient  1.007).  Additional evidence for 
the specificity and saturability of the binding of vimentin to 
IOVs was provided by quantitative competition assays, such 
as the ones shown in Fig. 3. The amount ofiodinated vimentin 
that  binds  to  erythrocyte  IOVs can  be  almost completely 
blocked by the addition of unlabeled vimentin, with a calcu- 
lated Ki of approximately 6 ×  10  -7 M. Comparable amounts 
of BSA (an acidic protein of approximately the same size as 
vimentin) were completely ineffective in influencing the bind- 
ing of vimentin to IOVs, as were other unrelated membrane 
proteins, described below. 
The  effects  of neutral  salt  solutions  on  the  binding  of 
vimentin to  IOVs is complicated and  dependent  upon  the 
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FIGURE 3  Competition between 1251-vimentin,  unlabeled vimentin 
(e), and  BSA (O)  for  binding to  IOVs.  Standard amounts of T2Sl- 
vimentin (final  concentration: 10 pg/ml)  were added to 20 ,ug of 
IOV together with  increasing  amounts of unlabeled vimentin or 
125  O  BSA. Bound  I-vimentin was quantitated as above. "100  Yo binding" 
was assigned to the samples containing only USl-vimentin  and IOVS. 
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concentration of vimentin used in the assays. At low vimentin 
concentration (10 pg/ml), binding to IOVs increased slightly 
when salt concentrations were raised to ~ 150 mM, but less 
protein remained bound with the membranes after salt con- 
centration exceeded 200 mM (Fig. 4A). Magnesium ions did 
not influence the binding. When the incubations were carried 
out at higher vimentin concentrations (36 #g/ml), more vi- 
mentin was bound to IOVs in the low salt solutions (Fig. 4B) 
than in higher salt. Since it has been reported that vimentin 
polymerization does not occur below 20 mM salt (31),  this 
experiment is consistent with the results using prepolymerized 
vimentin described above. When dilute solutions of vimentin 
were incubated with membranes, vimentin polymers would 
not be expected to form because of low protein concentration, 
and it is likely that binding under that condition reflected the 
true salt dependency of the vimentin-membrane interaction. 
When  higher  concentrations  of vimentin were used  in  the 
incubation, the protein which should have remained nonpo- 
lymerized  below  20  mM  salt  concentrations  undoubtedly 
began to self-associate to a small degree as the salt concentra- 
tion was raised. The varying degree of binding could be then 
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FIGURE 4  The effect of the ionic environment in the binding. (A) 
l~sI-Vimentin (at  10 #g/ml)  was reacted with 20/~g of IOV at the 
indicated ionic strength in either 5 mM NaPO4  and increasing NaCI 
{O) or 5 mM Tris-HCI, 2 mM MgCI2, and increasing KCI (A) at pH 
7.5 and 23°C. The highest binding values were considered "100% 
binding." (B) ~2Sl-Vimentin  (at 36/~g/ml) was assayed in the same 
way in 5 mM Tris-HCI, 2 mM MgCl2, and increasing KCl at pH 7.5 
and 23°C. (C) Time course of the binding. ~2sl-vimentin (10 #g/ml) 
was  incubated in  isotonic salt (PBS) with  20 /~g of IOVs  for the 
indicated time intervals. The time needed to process the samples 
for counting (12-15 min) was not taken into account. 
vimentin was then measured and expressed as a  function of 
the putative competitor concentration. 
Consistent  with  the  findings described  above, it was ob- 
served that a severalfold excess of ankyrin was able to inhibit 
80%  of the binding of the radiolabeled vimentin (Fig.  6A). 
This inhibition was of a competitive mode as indicated by the 
Dixon plots (Fig. 6 B). Much less inhibition is found with the 
other proteins tested (Fig.  6,  C-F). The amount of ankyrin 
needed  for quantitative vimentin displacement was greater 
than expected, because exogenously added  material reasso- 
ciated with the IOVs, leaving only a fraction of it in solution 
to act as a competitor (not shown). Surprisingly, the 43,000- 
mol-wt cytoplasmic peptide of band 3 had little effect on the 
binding (Fig.  6 C). This was unexpected since it was thought 
that  an  excess  of the  band  3  cytoplasmic  peptide  would 
probably displace  some ankyrin  from the  membranes and 
would thereby decrease the available vimentin binding sites. 
However, in  separate experiments it was  observed that  al- 
though  the  43,000-mol-wt  peptide  displaces  ankyrin  from 
urea-stripped,  ankyrin-reconstituted  vesicles,  that  does  not 
accounted for by the number of free ends of vimentin poly- 
mers that are actually exposed to receptor sites on the IOVs 
(31). 
The association of vimentin to IOVs proceeded relatively 
slowly at 23°C  and equilibrium was approached after a  90- 
min incubation (Fig.  4 C).  More prolonged incubations (>4 
h) resulted in a decrease in the binding of vimentin to mem- 
branes, but this is probably due to proteolytic degradation of 
the membranes that occurs under these conditions. 
Identification  of Vimentin  Binding Sites 
To identify the  nature of the binding site or sites on the 
exposed surfaces of IOVs, vesicles were treated with different 
proteolytic enzymes or with solvents capable of differentially 
extracting different classes of proteins from the membranes. 
Both trypsin and  1 M  acetic acid markedly reduced binding 
of vimentin to the membrane vesicles (Table I). Extraction of 
IOVs with  1 M  KCI, 0.4 M  urea at 0°C  selectively removed 
the bulk of protein 4.1  from the membrane while retaining 
80% of the ankyrin as has been reported (21).  Such vesicles 
stripped of most of protein 4.1  still  retained the capacity to 
bind  vimentin  (Fig.  5B).  In  contrast,  when  a  substantial 
amount  of the  ankyrin  was  stripped  from the  vesicles by 
treatment with 1 M KCI, 2.5 M urea at 37°C (14), the capacity 
of these stripped vesicles to  bind  vimentin was reduced  to 
25 % of the original activity (Fig. 5 B). When purified ankyrin 
was added back to the urea-stripped vesicles, much of vimen- 
tin's original  capacity to  bind  was restored  (Fig.  5 B).  The 
reconstitution of IOVs, depleted only of spectrin and actin, 
with purified spectrin did not significantly change the vimen- 
tin-binding capacity of vesicles (Fig. 5 A). Reconstitution with 
36 ~g/ml or  112 ~g/ml of purified spectrin did not alter the 
levels of vimentin binding (not shown). 
Ankyrin  Is a  Vimentin  Binding Site on  IOVs 
To further explore the possibility that ankyrin was respon- 
sible for the binding of vimentin to IOVs, a series of compe- 
tition  experiments were carried out.  A  standard amount of 
vesicles were incubated with ~25I-vimentin in the presence of 
ankyrin, protein 4. l, band 4.5, band 6, or the 43,000-mol-wt 
peptide derived from band 3 (23).  The percentage of bound 
TABLE  I 
Binding of 12sI-vimentin  to Various  Preparations  of Erythrocyte 
Membranes 
Percent binding 
with respect to 
Membranes  control 
Human erythrocyte IOVs 
Bovine erythrocyte IOVs 
Trypsinized IOVs (human) 
Acetic acid-treated IOVs (human) 
Stored IOVs (human) 
100 
104 
17.5 
3.6 
45 
Bovine  IOVs were  prepared  exactly the  same  way  as  the  human  IOVs. 
Trypsin  digestion  of human IOVs was achieved by a brief incubation of 2.9 
mg/ml of IOVs with 0.4 ~g/ml  of trypsin for 10 min at 23°C. The digestion 
was stopped by PMSF and the membranes were pelleted and washed 3 times 
with 5 mM NaPO4, 1 mM EDTA, 1 mM PMSF {pH 7.5). Acetic acid treatment 
involved  incubation of IOVs with  1 M  acetic acid at 0°C,  extensive  wash, 
and  brief dialysis against 5 mM  NaPO4, 1 mM  PMSF (pH  7.5). Stored  IOVs 
were assayed after having been left on ice for 10 d in 5 mM NaPO4, O.t  mM 
EDTA, 1 mM PMSF (pH  7.5). 
6O 
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Vimentin (/~/ml) 
FIGURE 5  (A)  Binding of vimentin to spectrin-reconstituted  IOVs. 
O,  nontreated IOV; 0, spectrin-reconstituted  Inv.  (B)  Binding of 
vimentin to various membrane preparations  after KCl-urea extrac- 
tion  or ankyrin-reconstitution. A,  Protein  4.1-depleted  IOV;  e, 
"stripped" IOV; 0, ankyrin-reconstituted ("stripped")  Inv.  For de- 
tails see Materials and Methods. 
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FIGURE 6  Competition assays. 12sl-Vimentin and  IOVs  were as- 
sayed in the presence of increasing amounts of exogenously  added 
ankyrin (A and  B);  protein 4.1  (C); 43,000-mol-wt peptide (from 
band 3, D); band 4.5  (E); and  band 6 (F). For details see Materials 
and Methods. 
happen  with the same efficiency in  unextracted IOVs (not 
shown). 
Further evidence that ankyrin is the vimentin binding site 
of IOVs was provided by preincubating IOVs with monospe- 
cific antibodies directed against different membrane proteins. 
Anti-ankyrin  antisera  completely inhibited  the  binding  of 
vimentin to IOVs (Fig. 7A). Antispectrin antisera had a small 
effect (Fig.  7B),  but  antisera  directed against  protein  4.1, 
glycophorin A, and the 43,000-mol-wt peptide derived from 
band 3 were completely ineffective (not shown). To ensure 
that the  inhibitory effect of anti-ankyrin was  not due to a 
cross-reaction with vimentin, gels containing IOVs,  isolated 
vimentin, ankyrin, or a crude lens extract (containing vimen- 
tin) were immunoblotted and tested for cross-reactivity with 
the anti-ankyrin antibody. As it could be seen in Fig. 8, even 
in overexposed autoradiograms such an effect is not detected. 
DISCUSSION 
Physiological Significance 
Although the terminally differentiated erythrocytes of the 
mammals lack intermediate filaments, the findings described 
above are likely to be of physiological relevance. The cyto- 
skeleton of immature erythrocytes (up to the orthoblast) is 
featured by a  well-developed network composed largely of 
vimentin filaments, which is lost after the expulsion of the 
nucleus (18,  19). Since ankyrin (constitutively present in all 
erythrocytes) plays a pivotal role in connecting the spectrin- 
actin meshwork to the membrane while retaining the ability 
to bind vimentin, it follows that a  fundamental regulatory 
mechanism  may  operate  in  vivo  to  control  the  selective 
linkage of membrane skeleton or/and the cytoskeleton to the 
lipid bilayer. Using various erythrocyte membrane constructs 
of defined protein composition and sideness  and exploiting 
the sensitive binding assays with purified vimentin, it seems 
now feasible to study the process of filament attachment on 
the molecular level (better depicted in the companion paper). 
In  addition,  the  main  corollaries of this  study could be 
applied to nucleated cells expressing both membrane skeleton 
components and the full complement of the cyto-skeleton. In 
fact, the widespread existence of "typical" erythrocyte mem- 
brane polypeptides in virtually every tissue examined, taken 
together with the limited complexity of the erythrocyte skel- 
eton present a paradox whereby filament-membrane interac- 
tions occurring in nucleated cells might be better analyzed in 
a model system that involves anucleate cells. 
Ankyrin as an Intermediate Filament 
Attachment Site 
The findings presented  here show that  soluble vimentin 
purified from lens tissue specifically associates with the inner 
surface of the human erythrocyte membrane under in vitro 
conditions.  By  several  criteria  we  have  identified ankyrin 
(band 2. l) as the vimentin acceptor site on IOVs.  Isolated 
ankyrin competes with the vimentin binding site.  If added 
exogenously, it restores the binding function to membranes 
that otherwise exhibit minimal binding as a  result of KC1- 
urea "stripping," and it exists in IOVs at approximately the 
same concentration as the vimentin acceptor (see also refer- 
ence 21).  Antibodies against ankyrin dramatically block the 
vimentin-membrane association while treatments known to 
modify ankyrin (trypsin, acetic acid) also reduce the binding 
of vimentin. 
Although these results specifically implicate ankyrin as a 
vimentin attachment site, it is conceivable that other binding 
sites may also exist for intermediate filament subunits. As a 
matter of fact, since our Scatchard analysis was not extended 
to vimentin concentrations greater than 100 pg/ml (to prevent 
self-association),  the existence of low-affinity sites cannot be 
excluded. In this regard, it is interesting that protein 4.1 shows 
a small but measurable ability to compete with the vimentin 
attachment site (approximately 30% inhibition). Although a 
direct interaction between vimentin and protein 4. l could not 
be documented in vitro (data not shown), it is worth pointing 
out that a 30% increase in the binding of ~25I-vimentin was 
observed after treating IOVs with affinity-purified  anti-protein 
4.1. 
Vimentin does not seem to interact directly with the spec- 
trin-actin network. IOVs reconstituted with spectrin do not 
show an increase in binding of vimentin, nor have we been 
able to detect complexes ofvimentin and spectrin or vimentin 
and actin that can be demonstrated by sedimentation analysis. 
Furthermore, vimentin does not form a ternary complex when 
co-incubated with spectrin and protein 4.1  as it happens in 
the case ofactin (Correas, I., and S. D. Georgatos, unpulished 
observations).  Since IOVs  reconstituted only with  spectrin 
show appreciable vimentin binding capacity, we would predict 
that  under native conditions the  vimentin binding site on 
ankyrin is not completely masked by spectrin. However, the 
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in vivo situation is complicated by a number of factors, among 
them the possible presence of spectrin oligomers attached to 
the inner surface of the membrane and to more than one site, 
and the possible effects of cross-linking of intermediate fila- 
ments  by  associated  proteins  (15).  For  these  reasons  the 
precise organization of the vimentin-ankyrin complex in situ 
cannot be approached only by studies of soluble proteins in 
~,itro. The findings described above differ significantly from 
previous studies in which it was suggested that a direct asso- 
ciation exists between  intermediate filaments and  the  lipid 
bilayer (16).  Both the binding features (saturability, number 
of acceptor sites,  etc.) and the fact that stripped or protease- 
treated membranes failed to bind vimentin are inconsistent 
with a simple, nonspecific association with membrane lipids. 
It is intriguing that ankyrin-like polypeptides have recently 
been identified in lens membranes (32),  an observation that 
raises the  possibility that  a  family of ankyrin-like proteins 
exist that provide attachment sites for intermediate filaments 
in a wide variety of eucaryotic cells.  In fact, recent observa- 
tions indicate that nonerythroid ankyrin occurs at a threefold 
excess over the  membrane-associated nonerythroid spectrin 
(33).  Thus,  even if all  spectrin  is exclusively bound  to  the 
membrane via ankyrin, there is additional ankyrin to be used 
for other functions. Although we do not have a clear picture 
of the  molecular  features  of the  ankyrin  molecule,  these 
findings and other related observations (34)  suggest  that an- 
kyrin has two functionally distinct domains, one a membrane- 
linking site and the other a multifunctional domain to which 
can be attached either spectrin or other components of the 
cytoskeleton.  If the  spectrin  attachment  site.and  the  inter- 
mediate filament binding regions are physically close to one 
another  as  we  suspect,  regulatory  "switching"  phenomena 
may occur that  could  be  involved  with  the  coupling  and 
uncoupling of membrane receptors with different components 
of the  cytoskeletal system. It is also interesting to  consider 
potential similarities between vimentin-ankyrin interactions 
and  those  that  have  been  reported  between  intermediate 
filaments (neurofilaments) and  microtubule-associated pro- 
teins (35).  Since a certain degree of functional and structural 
homology exists between ankyrin and microtubule-associated 
proteins,  the  types  of interactions  between  vimentin  and 
ankyrin detected in the erythrocyte may reflect more general 
mechanisms whereby microtubules, actin filaments, and in- 
termediate  filaments  form an  integrated  skeletal  unit  that 
regulates the structure and viscoelastic properties of both the 
membrane and the underlying cytoplasm. 
Attachment Pattern 
Vimentin filaments could bind to IOVs either by their "free 
ends" in an end-on fashion, or by a side-on association that 
FIGURE 8  Immunoblottingwith  the anti-ankyrin antibody. Proteins 
transferred  to  nitrocellulose sheets and  probed as  described  in 
Materials  and  Methods.  {A) Coomassie-stained  gel.  (B) Autoradi- 
ogram of a replica gel. Lane I, IOV's; lane 2, purified lens vimentin; 
lane 3, purified erythrocyte ankyrin; lane 4, KI Triton X-100-insol- 
uble residue of bovine lens. The autoradiogram was exposed for 5 
d at -70°C to bring about all possible cross-reacting protein species. 
could involve associations between multiple segments of the 
linear polymers. Since the binding of iodinated vimentin to 
IOVs (via ankyrin) is non-cooperative, and since bound sub- 
units do not seem to serve as filament nucleation  sites,  we 
favor an end-on binding mechanism. When measured under 
nonequilibrium conditions, nonassembled vimentin binds to 
a larger extent to IOVs than preassembled vimentin, possibly 
because of the higher concentration of free polymer ends (Fig. 
1 C).  In contrast, with a  hypothetical side-on mechanism in 
which  each  individual  subunit  along a  polymer should  be 
equally competent to bind,  identical binding curves should 
be  obtained  regardless  of the  polymerization  state  of the 
vimentin  preparation.  The  data  cannot  exclude  a  pattern 
whereby looping intermediate filaments attach to the mem- 
brane via short (proto)filament branches. In support of such 
a  model,  it  has been observed that  some intermediate fila- 
ments that connect keratin tonofilaments with desmosomal 
plaques have both  a  branching  morphology and  also have 
tiny rod-like bridges (36,  37). If the short rod-like bridges are 
1960  THE  JOURNAL  OF  CELL  BIOLOGY  .  VOLUME  100,  1985 actual attachment points, they might also be oriented in an
end-on fashion, even though the overall microscopic picture
is one of a combination of end-on and side-on orientations .
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